Ftse Mib
34.888,79
0,09%
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
NASDAQ
19.926,72
0,12%
Bitcoin
101.728,52
0,27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BeiGene Ltd (BGNE) BeiGene Ltd (BGNE) Notizie

BeiGene Ltd

BGNE
178,10
-2,17 (-1,20%)
14 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/12/202410:43BWBeiGene gibt globale Lizenzvereinbarung für MAT2A-Inhibitor..
13/12/202410:21BWBeiGene annonce un accord de licence mondial pour..
13/12/202401:30BWBeiGene Announces Global Licensing Agreement for MAT2A..
12/12/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202414:10BWベイジーンがASH..
11/12/202403:49BWBeiGene在ASH..
11/12/202403:45BWASH 2024: BeiGene stärkt Führungsposition bei CLL mit neuen..
11/12/202403:36BWBeiGene renforce son leadership dans la LLC à l’ASH 2024..
11/12/202402:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:26EDGAR2Form 144 - Report of proposed sale of securities
10/12/202412:02EDGAR2Form 8-K - Current report
10/12/202402:30BWBeiGene Advances Leadership in CLL at ASH 2024 with New Data..
04/12/202422:05EDGAR2Form SC 13D/A - General Statement of Acquisition of..
04/12/202412:00BWBeiGene and CLL Society Partner to Advance Test Before..
03/12/202403:45EDGAR2Form 144 - Report of proposed sale of securities
02/12/202412:01BWBeiGene to Host Investor Webcast Highlighting Key Data from..
29/11/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202422:35BWLa Commission européenne approuve TEVIMBRA de BeiGene pour..
27/11/202421:52BWEuropäische Kommission genehmigt BeiGenes TEVIMBRA für die..
27/11/202412:00BWEuropean Commission Approves BeiGene’s TEVIMBRA for..
26/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
26/11/202412:01BWBeiGene to Present at Upcoming Investor Conferences
19/11/202413:00PRNUSLabcorp CFO Glenn Eisenberg Announces Plans to Retire
19/11/202412:03EDGAR2Form 8-K - Current report
19/11/202412:00BWBeiGene Announces Settlement of Litigation Against Generic..
15/11/202413:25BWベイジーン、BeOne..
15/11/202413:23BWBeiGene dévoile son projet de changement de nom en BeOne..
15/11/202412:12BWBeiGene annonce ses résultats financiers du troisième..
15/11/202412:08BWベイジーン、2024年度第3四半期の決算結果と企業の最新情報を発表
15/11/202412:04BWBeiGene公布2024年第三季財務業績和公司最新進展
15/11/202402:11BWBeiGene gibt Finanzergebnisse für das dritte Quartal 2024..
14/11/202412:05EDGAR2Form 8-K - Current report
14/11/202412:00BWBeiGene Unveils Proposed Name Change to BeOne Medicines,..
12/11/202412:00BWBeiGene Announces Third Quarter 2024 Financial Results and..
08/11/202404:06BW百濟神州將在2024年ASH年會上重點展示跨B細胞惡性腫瘤的創新血液學產品組合
08/11/202401:47BWBeiGene präsentiert innovatives Hämatologie-Portfolio für..
06/11/202413:56BWベイジーン、ASH 2024でB細胞悪性腫瘍における革新的な血液学ポートフォリオを発表予定
06/11/202412:01BWBeiGene to Present at the Jefferies London Healthcare..
05/11/202423:17BWBeiGene présentera son portefeuille innovant d’hématologie..
05/11/202415:05BWBeiGene Highlights Innovative Hematology Portfolio Across..
28/10/202418:15BWBeiGene regrette le décès de Donald Glazer, membre bien-aimé..
28/10/202418:14BWBeiGene哀悼摯愛的董事會成員Donald Glazer的逝世
28/10/202411:00BWBeiGene Mourns Death of Beloved Board Member Donald Glazer
23/10/202414:24BWベイジーン、進行性/転移性胃がん、食道胃接合部がん、食道扁平上皮がんの一次治療薬となるTEVIMBRA®について、CHMPが肯定的見解を採択
22/10/202413:26BWBeiGene獲得CHMP對TEVIMBRA®做為晚期/轉移性胃癌或胃食管結合部癌和食管鱗狀細胞癌一線治療的肯定意見
22/10/202413:15BWBeiGene reçoit des avis positifs du CHMP pour TEVIMBRA® en..
22/10/202412:14BWBeiGene erhält positive CHMP-Stellungnahmen zu TEVIMBRA® als..
21/10/202412:00BWBeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a..
17/10/202412:23BWBeiGene met en avant l’innovation dans la macroglobulinémie..
Apertura: 177,15 Min: 176,15 Max: 179,65
Chiusura: 180,27

La tua Cronologia

NASDAQ
BGNE
BeiGene
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network